OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing

OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.